Adenokarsinoma Dokter Terbaik di Israel - TOP-21 dokter

Dr. Pelles Sharon berspesialisasi dalam pengobatan adenokarsinoma tingkat lanjut di Sourasky Medical Center, termasuk HIPEC dan imunoterapi.

• Ahli dalam Hyperthermic Intraperitoneal Chemotherapy (HIPEC) untuk kanker perut
• Menyediakan protokol imunoterapi yang dipersonalisasi termasuk Keytruda
• Melakukan penelitian klinis tentang sikap pasien terhadap uji klinis kanker
• Melakukan prosedur Whipple yang kompleks untuk adenokarsinoma pankreas

Kepala Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – Dr. Merimsky berspesialisasi dalam kasus sarkoma yang kompleks.

• Lebih dari 25 tahun pengalaman dalam onkologi ortopedi
• Menyelesaikan pelatihan fellowship di Institut Gustave Roussy di Paris
• Anggota ESMO Sarcoma Faculty dan IASLC
• Mempublikasikan banyak karya ilmiah tentang keganasan tulang dan jaringan lunak

Dr. Sarid spesialis dalam kemoterapi dan radioterapi dengan lebih dari 25 tahun pengalaman onkologi di Pusat Medis Sourasky (Ichilov) terkemuka di Israel.

• Pendidikan di Universitas Oxford dalam urologi kanker
• Peneliti utama untuk uji klinis dalam terapi kanker
• Penulis 30+ artikel tentang pengobatan kanker
• Anggota ESMO, ASCO, dan komunitas onkologi Israel

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Profesor Ido Wolf mengepalai departemen onkologi medis di Sourasky Medical Center terkemuka di Tel Aviv dan menyediakan konsultasi untuk opini kedua.

• Spesialisasi dalam memberikan opini kedua dalam konsultasi medis
• Pelatihan ekstensif di Sheba Medical Center dan Cedars-Sinai Medical Center
• Meraih gelar PhD dan peran pengajar akademik di Universitas Tel Aviv
• Anggota ASCO, AACR, dan organisasi onkologi internasional utama lainnya

Dr. Raphael memimpin prakarsa kedokteran genomik nasional Israel untuk onkologi dan merintis uji klinis dalam imunoterapi NSCLC.

• Dosen senior di Fakultas Ilmu Kedokteran Universitas Tel Aviv
• Peneliti utama untuk berbagai uji klinis imunoterapi NSCLC
• Moderator Dewan Tumor Molekuler Masyarakat Kanker Paru Israel
• Spesialisasi dalam pemprofilan genomik dan teknik biopsi cair
• Penerima keanggotaan ESMO dan IASLC

Kepala Departemen Bedah Kolorektal di Sourasky Medical Center (Ichilov) – seorang pakar dalam teknik terbuka dan invasif minimal.

• Lebih dari 20 tahun pengalaman bedah
• Spesialis terkemuka dalam melakukan prosedur Whipple yang kompleks
• Ahli bedah abdomen yang berfokus khusus pada bedah kanker

Direktur rawat inap onkologi di Ichilov, salah satu rumah sakit terkemuka di Israel, dan terlibat dalam uji klinis mutakhir sejak 2005.

• Lebih dari 20 tahun pengalaman klinis di bidang onkologi dan penyakit dalam
• Melakukan penelitian primer dan sekunder dalam studi onkologi fase I, II, dan III
• Memiliki izin praktik medis di Israel sejak Januari 2000
• Menjalani pelatihan onkologi melalui magang khusus di Tel Aviv Medical Center

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Karen Drumea adalah seorang Spesialis Radioterapi dan Onkologis di Rambam Medical Center, yang berfokus pada rencana perawatan yang tepat dan efektif.

• Spesialisasi dalam radioterapi untuk adenokarsinoma
• Bekerja di Rambam Medical Center, lembaga kesehatan terkemuka
• Berdedikasi pada perawatan pasien yang dipersonalisasi

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zalmanova berspesialisasi dalam radioterapi dengan fokus pada adenokarsinoma di Assuta Medical Center.

• Ahli radioterapi dengan keahlian dalam perawatan radiasi tertarget
• Bekerja di Assuta Medical Center, yang dikenal dengan perawatan onkologi mutakhir
• Menyusun rencana perawatan pribadi untuk pasien adenokarsinoma

Memimpin seluruh Pusat Onkologi sebagai Kepala Dokter di Assuta Medical Center.

• Spesialisasi dalam onkologi medis dan pengobatan kanker
• Memiliki pengalaman luas dalam mengelola kasus kanker yang kompleks
• Mengawasi perawatan pasien dan protokol departemen onkologi terkemuka